Skip to main content
. 2024 Aug 28;13(9):2804–2819. doi: 10.1021/acssynbio.4c00186

Figure 3.

Figure 3

Construct design and protein schematics of the engineered auxin biosensors. The single-fusion (in trans) designs consist of a Venus-Aux/IAA17 fusion and free mScarlet-I expressed from the same cistron. The bicistronic equine rhinitis B virus (ERBV) 2A self-cleaving peptide is inserted into the cassettes. The auxin receptor, TIR or AFB2, is expressed separately from another construct. The dual-fusion (in cis) designs consist of a Venus-Aux/IAA17 fusion and TIR1- or AFB2-mScarlet-I fusion expressed from a single mRNA with ERBV-2A inserted between them, offering fewer steps of genetic manipulation and cell transformation.